Catherine Harwood

Has grant

Professor of Dermatology

Queen Mary University of London - Whitechapel Campus

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Catherine Harwood is a faculty member in the Department of Dermatology at Queen Mary University of London - Whitechapel Campus. Her research focuses on various aspects of dermatology, including the healthcare resource use for atopic dermatitis, melanoma treatments, and the effects of systemic therapies. She has contributed significantly to understanding adverse effects of cancer treatments and strategies for skin cancer prevention in organ transplant recipients.

Recent Grants

Grant: Open

Adjuvant radiotherapy in patients with high-risk primary cSCC AFTER surgery (SCC-AFTER): an open label, multicentre, two-arm phase III randomised trial.

Open Date: 2023-01-01

Close Date: 2030-12-01

Grant: Close

Cancer associated fibroblasts in cutaneous squamous cell cancer: defining the therapeutic potential of their epigenetic and transcriptional regulation

Open Date: 2022-05-01

Close Date: 2025-05-01

Grant: Close

Keratinocyte Cancer Collaborative pilot Atlas for cSCC

Open Date: 2022-02-01

Close Date: 2025-02-01

Grant: Close

Barts Centre for Squamous Cancer: A Centre of Excellence for Squamous Cancer

Open Date: 2021-09-01

Close Date: 2026-09-01

Grant: Close

Defining the role of the IgE-Fc epsilon receptor-1 immune surveillance axis in human cutaneous squamous cell carcinoma

Open Date: 2021-09-01

Close Date: 2024-02-01

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (26)

Carla Ferrandiz-Pulido

Assitant Professor

University of Barcelona

SPAIN

Catherine Harwood

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

A Real-World Data Study on the Healthcare Resource Use for Uncontrolled Moderate-to-Severe Atopic Dermatitis in Secondary Care in the United Kingdom Prior to the Introduction of Biologic Treatment.

Decosus: An R Framework for Universal Integration of Cell Proportion Estimation Methods.

Implications of systemic adjuvant melanoma treatments for U.K. melanoma services: Results of the U.K. Melanoma Adjuvant Pathway Survey.

Melanoma in pregnancy: Diagnosis and management in early-stage and advanced disease.

Small vessel vasculitis and dry gangrene secondary to combined CTLA-4 and PD-1 blockade in malignant mesothelioma.

Adverse Effects of Vemurafenib on Skin Integrity: Hyperkeratosis and Skin Cancer Initiation Due to Altered MEK/ERK-Signaling and MMP Activity.

Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.

Collaborators (26)

Carla Ferrandiz-Pulido

Chee Kay Cheung

Hugh Welch

Vishal Dey

Emmanuelle Denis

Polly Black

N. A. Kametas

José M. Mascaró

manu vatish

Michael CARTER

Kathryn Puxty

Huzaifa Adamali

Lyrics Noba

Dermot Linden

Beatriz Duran Jimenez

Stephanie Hatch

Geeshath Jayasekera

Maheshi N Ramasamy

Shaman Jhanji

Nazima Pathan

Chinedu Anene

Xin Hui Chan

Ingeborg Welters

Joseph Lewis

Anthony Yong Kheng Cordero Ng

Tom Dymond

Make your next move.